Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Palantir

Google Leads 4 AI Stocks Battling Back Toward Buy Points. Why They Deserve A Close Look.

Google leads this week's list of AI stocks that are rebounding back near buy points after recent sell-offs.

Investors Business Daily

Palantir Receives $115 Million Army Contract Extension; PLTR Stock Pushes Higher Before Closing Flat

PLTR stock briefly traded higher early Friday on a one-year extension of Palantir's contract with the U.S. Army.

Investors Business Daily

Palantir Stock Briefly Reclaims 50-Day Average Before Giving Up Gains

Palantir stock, which sank more than 12% last week, advance early Monday before giving up those gains to trade flat.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Cathie Wood snaps up 1.5 million shares of Palantir following stock tumble

One analyst warned against possible future difficulties for the company.

The Street

Is Palantir Stock Really Headed to Just $5 Per Share?

Palantir stock has more than doubled in 2023, but lost 9% to start the week after a bearish analyst note. Are concerns about the AI software company's contract pipeline overdone, or is major downside ahead for the stock in 2024?

Barchart

Palantir Falls As Analyst Raises Questions Over Army Contract Renewal

Palantir stock's strong run in 2023 is running into more headwinds with a bearish analyst on PLTR stock raising questions over an Army contract renewal.

Investors Business Daily

Palantir Still Has Room to Rise, and Could Be Worth Up to 20% More

Palantir stock is still undervalued given its powerful free cash flow. With a 27% FCF margin and an FCF yield of 1.5% PLTR stock is worth 20% more. Shorting OTM puts is a good income play.

Barchart

Read news from The Economist, FT, and more,
with one subscription

You may balk at giving your health data to Palantir but it could save your life

The NHS’s deal with the US tech company raises privacy concerns but a unified database could be a medical gamechanger

The Guardian - UK

Dow Jones Futures Fall; ARM, Palantir Lead 7 Stocks In Buy Areas

Futures signaled a lower open Monday. Arm Holdings and D.R. Horton flashed buy signals Friday.

Investors Business Daily

Palantir: privacy fears over handing NHS data to US defence provider show how lack of trust is holding back much-needed reform

Controversial US tech company Palantir has been awarded a £330 million contract to create a new system for sharing data – including patients’ medical details – within the NHS in England.

The Conversation

SNP MP grills Rishi Sunak over US tech firm's NHS contract

SNP MP Deidre Brock grilled Rishi Sunak at PMQs on Wednesday over NHS England’s awarding of an IT contract to US tech firm Palantir.

The National (Scotland)

Dow Jones Futures Rise: Market Holds Strong, Tesla, Palantir Rally; Two Big Earnings Winners

The major indexes held near 2023 highs Tuesday. Tesla cleared a key level heading into the Cybertruck delivery event.

Investors Business Daily

The Guardian view on the NHS and Palantir: the case for this data deal looks weak

Editorial: Hiring a controversial US technology company to build an NHS data platform risks undermining public trust

The Guardian - UK

13 inflation-proof stocks to buy for 2024

These companies are poised to ride the AI boom and protect investors from the impact of higher interest rates.

Fortune

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Tech firm Palantir rejects concerns over role in NHS data platform plans

US tech giant Palantir has rejected concerns after the firm was awarded a contract worth hundreds of millions of pounds for a new NHS data platform.

Fortune

Peter Thiel-cofounded Palantir will overhaul the U.K.’s public health service in a deal worth up to $413m—and people are worried

Palantir previously worked with the NHS during COVID-19, helping with vaccine rollout for a grand sum of £1. But people remain skeptical about the deal.

The Independent UK

MPs to press new Health Secretary on NHS data platform plans

The health and social care committee said the Government has acknowledged it ‘needed to do better to communicate the benefits of digital healthcare’.

Investors Business Daily

Dow Jones Futures Rise: Nvidia Earnings Skyrocket Again On AI Boom; Altman Back At OpenAI

Nvidia earnings soared and revenue tripled, with the AI chip leader guiding up again, but is that enough for NVDA stock?

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

Palantir’s Peter Thiel: NHS is a natural target for outspoken tech billionaire

Silicon Valley outsider whose firm has won data contract has previously said health service should be ripped up to ‘start over’

The Guardian - UK

Patient privacy fears as US spy tech firm Palantir wins £330m NHS contract

Awarding of contract to create new data platform prompts immediate concerns about security of medical records

The Guardian - UK

TechScape: Are social media giants silencing online content?

As violence on the ground continues, emotions on social media are higher than ever – with critics asking if platforms need more transparency around their algorithms

The National (Scotland)

NHS England gives contract to handle patient data to US spy tech firm

NHS England is set to hand over a key role in handling patient data to a US spy technology firm.

The Guardian - UK

NHS England gives key role in handling patient data to US spy tech firm Palantir

Exclusive: Company that works with intelligence services wins £480m contract in joint bid with Accenture

Investors Business Daily

Dow Jones Futures: Ousted OpenAI CEO Joins Microsoft; Nvidia Earnings Key For These 6 AI Stocks

The market is near a power trend. Ex-OpenAI CEO Sam Altman will join Microsoft. Nvidia earnings are key for AI stocks.

Barchart

Is It Too Late to Buy Palantir Stock?

Palantir stock has more than tripled in 2023, delivering outsized gains for shareholders. But it now trades at a premium valuation, and may pull back in the near term.

1 … 10 11 12 13

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations